The Dermatologist's Approach to Onychomycosis
- PMID: 29376907
- PMCID: PMC5753109
- DOI: 10.3390/jof1020173
The Dermatologist's Approach to Onychomycosis
Abstract
Onychomycosis is a fungal infection of the toenails or fingernails that can involve any component of the nail unit, including the matrix, bed, and plate. It is a common disorder that may be a reservoir for infection resulting in significant medical problems. Moreover, onychomycosis can have a substantial influence on one's quality of life. An understanding of the disorder and updated management is important for all health care professionals. Aside from reducing quality of life, sequelae of the disease may include pain and disfigurement, possibly leading to more serious physical and occupational limitations. Dermatologists, Podiatrists, and other clinicians who treat onychomycosis are now entering a new era when considering treatment options-topical modalities are proving more effective than those of the past. The once sought after concept of viable, effective, well-tolerated, and still easy-to-use monotherapy alternatives to oral therapy treatments for onychomycosis is now within reach given recent study data. In addition, these therapies may also find a role in combination and maintenance therapy; in order to treat the entire disease the practitioner needs to optimize these topical agents as sustained therapy after initial clearance to reduce recurrence or re-infection given the nature of the disease.
Keywords: maintenance; onycholysis; onychomycosis; recurrence; subungual hyperkeratosis.
Conflict of interest statement
Dr. Queller has no conflicts of interest. Dr. Bhatia is an advisor, consultant, investigator, and speaker for Anacor, Merz, Sandoz, and Valeant.
Similar articles
-
Onychomycosis: An Updated Review.Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):32-45. doi: 10.2174/1872213X13666191026090713. Recent Pat Inflamm Allergy Drug Discov. 2020. PMID: 31738146 Free PMC article. Review.
-
The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.J Clin Aesthet Dermatol. 2014 Jul;7(7):10-8. J Clin Aesthet Dermatol. 2014. PMID: 25053979 Free PMC article. Review.
-
Onychomycosis: burden of disease and the role of topical antifungal treatment.J Drugs Dermatol. 2013 Nov;12(11):1263-6. J Drugs Dermatol. 2013. PMID: 24196334
-
Onchomycosis: an overview.J Drugs Dermatol. 2013 Jul 1;12(7):s96-103. J Drugs Dermatol. 2013. PMID: 23884508
-
[Etiopathogenesis, clinical picture and diagnosis of onychomycoses].Med Pregl. 2001 Jan-Feb;54(1-2):45-51. Med Pregl. 2001. PMID: 11432322 Review. Croatian.
Cited by
-
In Vitro Combination Effect of Topical and Oral Anti-Onychomycosis Drugs on Trichophyton rubrum and Trichophyton interdigitale.J Fungi (Basel). 2021 Mar 12;7(3):208. doi: 10.3390/jof7030208. J Fungi (Basel). 2021. PMID: 33809181 Free PMC article.
-
Onychomycosis: An Updated Review.Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):32-45. doi: 10.2174/1872213X13666191026090713. Recent Pat Inflamm Allergy Drug Discov. 2020. PMID: 31738146 Free PMC article. Review.
-
Efficacy of Bovine Nail Membranes as In Vitro Model for Onychomycosis Infected by Trichophyton Species.J Fungi (Basel). 2022 Oct 27;8(11):1133. doi: 10.3390/jof8111133. J Fungi (Basel). 2022. PMID: 36354900 Free PMC article.
-
Optimization of Drug Permeation from 8% Ciclopirox Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers.Pharmaceutics. 2020 Mar 5;12(3):231. doi: 10.3390/pharmaceutics12030231. Pharmaceutics. 2020. PMID: 32151015 Free PMC article.
-
ONYCHOMYCOSIS: A Review of New and Emerging Topical and Device-based Treatments.J Clin Aesthet Dermatol. 2019 Oct;12(10):29-34. Epub 2019 Oct 1. J Clin Aesthet Dermatol. 2019. PMID: 32038746 Free PMC article. Review.
References
-
- Scher R.K., Daniel C.R., III . Nails: Therapy, Diagnosis, Surgery. 3rd ed. Elsevier Saunders; Philadelphia, PA, USA: 2005. pp. 127–170.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous